<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04828655</url>
  </required_header>
  <id_info>
    <org_study_id>UA-2020-04-16</org_study_id>
    <nct_id>NCT04828655</nct_id>
  </id_info>
  <brief_title>Analysis of Bioparametric Measures for Correlating Daily Habits and Reducing Blood Pressure</brief_title>
  <official_title>Análisis de Medidas bioparamétricas Para Correlacionar Los hábitos Diarios y Reducir la tensión Arterial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alicante</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alicante</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the effects of the use of a mobile application plus recommendations based on a&#xD;
      Mediterranean diet on the intake of micronutrients from natural sources (not drugs) on health&#xD;
      indicators, cardiovascular parameters (blood pressure...), physical condition and body&#xD;
      composition in a Spanish adult population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the Valencian Community, 93% of deaths appear to be related to (non-communicable) diseases&#xD;
      such as: obesity, hypertension and diabetes. In 2013, cardiovascular diseases were the&#xD;
      leading cause of death in women (34.4%) and the second in men (28.0%). There is a forecast&#xD;
      that overweight and obesity will reach levels of 89% and 85% in men and women, respectively,&#xD;
      by 2030. This will result in an increase in the obesity-related prevalence of coronary heart&#xD;
      disease by 97%. The promotion of research on arterial hypertension and how it could be&#xD;
      reduced is one of the basic pillars in decreasing the prevalence and incidence in the Spanish&#xD;
      population. Research should anticipate and develop treatments and vaccines that prevent new&#xD;
      scenarios of widespread infection.&#xD;
&#xD;
      Therefore, the main objective is to study the effects of the use of a mobile application plus&#xD;
      recommendations based on a Mediterranean diet on the intake of micronutrients from natural&#xD;
      sources (not drugs) on health indicators, cardiovascular parameters (blood pressure...),&#xD;
      physical condition and body composition in the adult Spanish population.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Actual">May 31, 2021</completion_date>
  <primary_completion_date type="Actual">January 7, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular variables; heart rate.</measure>
    <time_frame>9 months</time_frame>
    <description>Heart rate measurement done with an activity wristband.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular variables; blood pressure.</measure>
    <time_frame>9 months</time_frame>
    <description>Measurement of blood pressure (systolic and diastolic) with a digital tensiometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physical condition; time.</measure>
    <time_frame>9 months</time_frame>
    <description>The evaluation of the physical condition will be carried out by means of the mile test, in which the subjects have to cover this distance walking, and in the shortest possible time.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Composition - Bioimpedance</measure>
    <time_frame>9 months</time_frame>
    <description>Assessment of body composition using the TANITA (Tokyo, Japan) validated bioimpedance scale to obtain the results of fat mass, fat-free mass and visceral mass.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight</measure>
    <time_frame>9 months</time_frame>
    <description>The weight of the subjects will be obtained using the TANITA (Tokyo, Japan). From the body mass and height data, the BMI (kg/m2) will be obtained.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Height</measure>
    <time_frame>9 months</time_frame>
    <description>The height of the subjects will be measured with the SECA 123 stadiometer (Hamburg, Germany). From the body mass and height data, the BMI (kg/m2) will be obtained.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Composition - Skinfolds</measure>
    <time_frame>9 months</time_frame>
    <description>The kinanthropometric assessment will be carried out using the methodology proposed for the restricted profile by the International Society for the Development of Kineanthropometry (ISAK). The material used to measure skinfolds will be a plicometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Composition - Perimeters</measure>
    <time_frame>9 months</time_frame>
    <description>The kinanthropometric assessment will be carried out using the methodology proposed for the restricted profile by the International Society for the Development of Kineanthropometry (ISAK). The material used to measure perimeters will be a tape.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body Composition - Diameters</measure>
    <time_frame>9 months</time_frame>
    <description>The kinanthropometric assessment will be carried out using the methodology proposed for the restricted profile by the International Society for the Development of Kineanthropometry (ISAK). The material used to measure diameters will be a pachymeter.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Hypertension</condition>
  <condition>Diet, Mediterranean</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Exercise</condition>
  <condition>Machine Learning</condition>
  <condition>Overweight and Obesity</condition>
  <condition>Body Composition</condition>
  <condition>Triglyceride-Storage; Disease</condition>
  <arm_group>
    <arm_group_label>CONTROL GROUP</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Recommendations on healthy eating habits based on the Mediterranean diet and moderate physical activity. Specific micronutrient intake focused on improving cardiovascular parameters and body composition.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EXPERIMENTAL GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recommendations on healthy eating habits based on the Mediterranean diet and moderate physical activity through an application based on machine learning. Intake of specific micronutrients focused on improving cardiovascular parameters and body composition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Use of a mobile application based on machine learning with the aim of improving health and body composition parameters.</intervention_name>
    <description>Specific diet program and moderate physical activity, all guided and mediated by a mobile application. As well as the recording and monitoring of periodic evaluations of health indicators.</description>
    <arm_group_label>EXPERIMENTAL GROUP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Over 40 years old&#xD;
&#xD;
          -  Healthy.&#xD;
&#xD;
          -  Blood pressure levels slightly elevated but less than 140 mm Hg and/or diastolic&#xD;
             pressure less than 90 mm Hg.&#xD;
&#xD;
          -  Smartphone access&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects with diseases.&#xD;
&#xD;
          -  Consumption of drugs and/or supplements.&#xD;
&#xD;
          -  Subjects with food intolerances/allergies.&#xD;
&#xD;
          -  Subjects with muscle or joint injury.&#xD;
&#xD;
          -  Subjects with impossibility to follow up the intervention.&#xD;
&#xD;
          -  Refusal of informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alejandro Martínez Rodríguez</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alicante University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alejandro Martínez Rodriguez</name>
      <address>
        <city>Alicante</city>
        <zip>03690</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alicante</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Alejandro Martínez-Rodríguez</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

